Bio-Imaging Tech sells CapMed to focus on clinical

08-Jan-2009 - Contract research organisation Bio-Imaging Technologies has decided to sell off its CapMed subsidiary in order to focus its efforts on its core business, providing imaging series to clinical investigators.

India a ‘hot’ destination for clinical trials

08-Jan-2009 - The proportion of global clinical trials conducted In India is expected to more than double between 2007 and 2012, according to market research firm RNCOS.

ICTS unit will help pharma’s message reach doctors

06-Jan-2009 - US contract research organisation Integrated Clinical Trial Services has set up a team that will help pharmaceutical companies communicate information on their products to the medical community.

New CEO at microdosing specialist Xceleron

18-Dec-2008 - Dr. Michael Butler has joined Xceleron as chief executive bringing an end to a search to replace Prof Colin Garner, the firm’s founder, who is retiring from the post.

Keep clinical trial patients ‘in the loop’, say researchers

18-Dec-2008 - There is no formal requirement to inform clinical trial participants of the results of the study, a situation which can leave them “confused, frustrated and, in some cases, lacking information that may be important to their health,” according to a report in the journal Archives of Neurology.

Icon boosts bioanalytical presence through Prevalere buy

08-Dec-2008 - Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a busy AAPS conference in Atlanta.

Bilcare boosts clinical trial supply business in India

08-Dec-2008 - India’s Bilcare has expanded its clinical trial materials business in its own market with the opening of new packaging and storage capacity at its facilities in Pune, India.

Quintiles gets bigger in cancer with TMD purchase

02-Dec-2008 - Quintiles Transnational has boosted its array of services for companies developing cancer drugs via the purchase of Illinois, US-based firm Targeted Molecular Diagnostics.

Tigermed, OCT and LSK to set up global trials network

25-Nov-2008 - Chinese CRO Tigermed Consulting has teamed up with Russian and South Korean counterparts OCT and LSK to establish a global clinical trials network and expand its geographic footprint.

Azopharma adds microdosing to service portfolio

23-Oct-2008 - Contract drug development company Azopharma Product Development has set up a new business unit to cater for companies wanting to run microdosing or so-called Phase 0 studies.

Multi-study advances HIV drug to Phase II quicker

21-Oct-2008 - Pharmaceutical Profiles of the UK has completed a groundbreaking study that bundles together a number of tests used to decide whether a drug development candidate is worth pursuing into a single clinical trial.

Parexel sets up proof-of-concept unit

02-Oct-2008 - Parexel International has expanded its early phase drug development capabilities with a unit focused specifically on proof of concept studies.

Publication bias emerges again in clinical research

30-Sep-2008 - Clinical trials that support the effectiveness of drugs filed for approval in the US are more likely to be published than those that are less supportive, according to researchers at the University of California at San Francisco.

Outsourcing drives growth in trial sector, Bilcare GCS

16-Sep-2008 - Bilcare GCS, the clinical supplies arm of Indian packaging giant Bilcare, has considerably expanded its Phase III trial offering in an effort to provide drugmakers with a complete package.

Phase Forward buys Clarix for $40m

09-Sep-2008 - eClinical specialist Phase Forward has added to its portfolio by purchasing interactive-response technology company Clarix for $40m in cash in a move aimed at toppling ClinPhone from its leading position in the sector.

EU’s Clinical Trial Directive ‘put no brake on trials’

02-Sep-2008 - Contrary to fears, the European Union’s Clinical Trials Directive has not had an inhibitory effect on the number of studies carried out by publicly-funded researchers, at least in Denmark.

EDC helps Phase Forward march ahead in 2Q

29-Jul-2008 - Like many of its peers in the contract clinical research sector, data management specialist Phase Forward put in another bumper financial performance in the second quarter headed by a 30 per cent hike in revenues to $41m.

ClinPhone forms adaptive trials partnership

03-Jul-2008 - ClinPhone has formed a partnership that is aimed at giving it the edge in the evolving adaptive trials technology sector.

New data adds weight to case for microdosing

24-Jun-2008 - Newly-released data appears to add weight to the case for microdosing as a means to more accurately predict pharmacological dose absorption, metabolism, distribution and elimination (ADME) and pharmacokinetic (PK) outcomes in drug development.

eClinical potential explored

05-Dec-2007 - As eClinical gathers momentum, Outsourcing-Pharma.com spoke to two contract research organisations (CROs), Icon and Parexel, to get their views on the present and future of these emerging technologies.

Industry bodies call for EU clinical trials directive changes

18-Oct-2007 - Two major bioscience industry trade associations have called for changes to be made to the European clinical trials directive in order to bring about "harmonisation, transparency and consistency" in this area across the member states.

Weekly comment

UK tightens Phase I guidelines

21-Aug-2007 - The Association of the British Pharmaceutical Industry (ABPI) has now published revised guidelines for Phase I trials in the UK.

Adaptive trials are heating up

05-Jul-2007 - Adaptive trials were a hot topic at this year's Drug Information Association (DIA) Annual Meeting, held in Atlanta. The first of a free seminar series on the subject will also be run by three industry pioneers next week.

New simulator touts adaptive trial savings

15-Mar-2007 - In anticipation of a new wave of adaptive clinical trials, UK firm Tessella has designed a software system to help pharma firms conduct seamless trials that could ultimately save time and money.